Driving Precision Delivery & Scalable Manufacturing for The Next Wave of Exosome-Based Therapeutics

Optimizing Clinical Trials for Exosome & Extra-Cellular Vesicle Therapies & Scaling Manufacturing & Analytical Testing to Accelerate Regulatory Approval, Maximize Investments & De-Risk Platform Development

The exosome therapeutics field is entering a pivotal phase, with companies such as Rion and Capricor Therapeutics advancing into later-stage clinical development beyond Phase 1 and 2 trials. As the pipeline matures, rising regulatory expectations are accelerating the need to evolve exosome platforms into scalable, compliant, and commercially viable therapies. Successfully navigating this transition will require strong industry alignment across clinical strategy, manufacturing, analytics, and regulatory pathways to unlock the next wave of exosome-based therapeutics.

The 8th Exosome-Based Therapeutics Summit returns to Boston, providing a premier platform to connect with leaders in clinical development and manufacturing. Join peers to streamline your CMC strategies, advance your clinical programs, and accelerate your path toward regulatory approval and commercialization.

Networking since the conference was small but had a critical mass. The sessions were well organized and provided cutting edge science and status of ongoing clinical trials in the exosome space

Kuldeep Neote, Chief Executive Officer, Diadem Biotherapeutics

The size of the conference was great, I especially liked that you got the regulatory person to attend because this is usually the missing part of the discussion that is so crucial to cover

Suvi Aivio, Director- Cell Therapy, Edge Animal Health

Excellent content, good thought-leaders, and easy to build networks”-

Joe Barendt, Senior Director, International Business Development, Daicel USA

Explore the Full Event Guide

  • Get a full overview of the agenda, speakers, and sessions in one place
  • Preview featured clinical trials that we’ll be shining a light on
  • Discover exclusive content such as keynote highlights, attendee benefits and more
  • Share easily with colleagues and decision-makers
7th Exosome-Based Therapeutic Development Summit brochure image

What To Expect

30+

Companies in Attendance

60%

Biopharma Companies

7+

Hours of Networking

3

Clinical Data Updates

2

Roundtable Discussions

1

Pre-Conference Focus Day

Official Partners

Expertise Partners

Exhibition Partners

Innovation Partner

Official Partners

Expertise Partners

Exhibition Partners

Innovation Partner

Attending Companies Include

Rion - 8th Exosome-Based Therapeutic Development Summit
Aegle Therapeutics - 8th Exosome-Based Therapeutic Development Summit
Takeda - 8th Exosome-Based Therapeutic Development Summit
NIH - 8th Exosome-Based Therapeutic Development Summit
Versatope Therapeutics - 8th Exosome-Based Therapeutic Development Summit
Explore-the-Agenda-768x512

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

Partner-With-Us-768x512

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Join-LNP-Experts-768x512

Join Exosome-Based Therapy Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.